menu

KOL Knockout™: Cancer Pain Management Edition

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

KOL Knockout™: Cancer Pain Management Edition

1.50 credits
90 minutes
ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
1.50 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    This enduring program of the live-virtual symposium will focus on the challenges of managing cancer pain using the Evolve KOL Knockout™ case-based format. The key opinion leaders (KOLs) will be challenged by the host/moderator to diagnose and manage patient scenarios with varying levels of difficulty. Learners will vote on the winner of each case presentation round and the moderator will declare a match winner at the conclusion.

    There will be learning, laughter, and only one KOL left standing! 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, the IASLC and Evolve Medical Education require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. The IASLC and Evolve Medical Education mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Pranshu Mohindra, MD
    Vice-Chair of Operations and Quality, Department of Radiation Oncology, UH Cleveland Medical Center,
    Director, UH Proton Therapy Center
    UH Seidman Cancer Center
    Faculty, Case Western Reserve University School of Medicine
    Cleveland, OH

    No relevant relationships reported

    Faculty:
    Melissa Teply, MD 
    Associate Professor in Geriatrics, Gerontology, and Palliative Medicine
    University of Nebraska Medical Center
    Omaha, NE

    No relevant relationships reported

    Judith A. Paice, PhD, RN
    Director, Cancer Pain Program
    Division, Hematology-Oncology
    Northwestern University; Feinberg School of Medicine
    Chicago, IL

    No relevant relationships reported

    Fionnuala Crowley, MD
    Integrated Oncology and Palliative Care Fellow
    Department of Hematology Oncology
    Department of Geriatrics and Palliative Care
    Icahn School of Medicine at Mount Sinai
    New York, NY

    No relevant relationships reported

    Reviewers/Content Planners/Authors:
    The Evolve & IASLC staff, planners and peer reviewer have no financial relationships with ineligible companies.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Discuss the National Comprehensive Cancer Network cancer pain management guidelines
    • Illustrate how to effectively assess and screen cancer patients who require pain management
    • Determine when to re-evaluate the need for long-term pain management
    • Outline pharmacological options and alternate therapies for treating cancer pain
    • Apply proper patient communication strategies
    • Formulate a plan to ween cancer patients from various pain management strategies when appropriate
    • Explain opiate dosing, titration, and adverse effects regarding the pain management options
  • Target Audience

    This certified CE/CME activity is designed for specialty physicians, nurses, physician assistants, and nurse practitioners who treat cancer patients.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The International Association for the Study of Lung Cancer (IASLC) and Evolve Medical Education (Evolve). IASLC is accredited by the ACCME to provide continuing medical education for physicians.

    Physicians
    The International Association for the Study of Lung Cancer designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Registered Nurses
    Evolve is approved by the California Board of Registered Nursing, Provider Number 17004, for 1.5 contact hours.

    Physician Assistants
    PAs may claim a maximum of 1.5 Category 1 credit for completing this activity. The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

    Nurse Practitioners
    The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines. 

  • Provider(s)/Educational Partner(s)


    Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients

    MISSION 
    Be the multidisciplinary world authority on lung and other thoracic cancers through collaborative science, education, and advocacy in order to ensure optimal prevention and patient care.

  • Commercial Support

    This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of IASLC, Evolve, or the Opioid Analgesic REMS Program Companies.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    This enduring program of the live-virtual symposium will focus on the challenges of managing cancer pain using the Evolve KOL Knockout™ case-based format. The key opinion leaders (KOLs) will be challenged by the host/moderator to diagnose and manage patient scenarios with varying levels of difficulty. Learners will vote on the winner of each case presentation round and the moderator will declare a match winner at the conclusion.

    There will be learning, laughter, and only one KOL left standing! 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, the IASLC and Evolve Medical Education require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. The IASLC and Evolve Medical Education mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Pranshu Mohindra, MD
    Vice-Chair of Operations and Quality, Department of Radiation Oncology, UH Cleveland Medical Center,
    Director, UH Proton Therapy Center
    UH Seidman Cancer Center
    Faculty, Case Western Reserve University School of Medicine
    Cleveland, OH

    No relevant relationships reported

    Faculty:
    Melissa Teply, MD 
    Associate Professor in Geriatrics, Gerontology, and Palliative Medicine
    University of Nebraska Medical Center
    Omaha, NE

    No relevant relationships reported

    Judith A. Paice, PhD, RN
    Director, Cancer Pain Program
    Division, Hematology-Oncology
    Northwestern University; Feinberg School of Medicine
    Chicago, IL

    No relevant relationships reported

    Fionnuala Crowley, MD
    Integrated Oncology and Palliative Care Fellow
    Department of Hematology Oncology
    Department of Geriatrics and Palliative Care
    Icahn School of Medicine at Mount Sinai
    New York, NY

    No relevant relationships reported

    Reviewers/Content Planners/Authors:
    The Evolve & IASLC staff, planners and peer reviewer have no financial relationships with ineligible companies.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Discuss the National Comprehensive Cancer Network cancer pain management guidelines
    • Illustrate how to effectively assess and screen cancer patients who require pain management
    • Determine when to re-evaluate the need for long-term pain management
    • Outline pharmacological options and alternate therapies for treating cancer pain
    • Apply proper patient communication strategies
    • Formulate a plan to ween cancer patients from various pain management strategies when appropriate
    • Explain opiate dosing, titration, and adverse effects regarding the pain management options
  • Target Audience

    This certified CE/CME activity is designed for specialty physicians, nurses, physician assistants, and nurse practitioners who treat cancer patients.

  • Accreditation and Credit Designation Statements

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The International Association for the Study of Lung Cancer (IASLC) and Evolve Medical Education (Evolve). IASLC is accredited by the ACCME to provide continuing medical education for physicians.

    Physicians
    The International Association for the Study of Lung Cancer designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Registered Nurses
    Evolve is approved by the California Board of Registered Nursing, Provider Number 17004, for 1.5 contact hours.

    Physician Assistants
    PAs may claim a maximum of 1.5 Category 1 credit for completing this activity. The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

    Nurse Practitioners
    The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines. 

  • Provider(s)/Educational Partner(s)


    Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients

    MISSION 
    Be the multidisciplinary world authority on lung and other thoracic cancers through collaborative science, education, and advocacy in order to ensure optimal prevention and patient care.

  • Commercial Support

    This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of IASLC, Evolve, or the Opioid Analgesic REMS Program Companies.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule3 Mar 2024